首页> 外国专利> A method to Prolong the survival of renal allograft, using an Antibody anti CD200 to Prolong allograft Survival

A method to Prolong the survival of renal allograft, using an Antibody anti CD200 to Prolong allograft Survival

机译:一种使用抗CD200抗体来延长同种异体移植存活时间的延长肾脏同种异体移植存活时间的方法

摘要

The description also provides biomarkers, a change in one or more of which indicate that an Antibody anti CD200 has been an immunomodulatory effect desired in a Mammal. Mention is also Pharmaceutical compositions, kits, and Solutions containing at least one Antibody anti CD200 and are useful in the methods described herein.Claim 1: a method to Prolong the survival of renal allograft. The Method comprises administering to a Mammal in need a receiver that CD200 Antibody as a Single Agent in an amount and often effective to Prolong the survival of allograft ren In the mammalian host.Claim 32: The Method according to claim 21 to 25, which Selects at least one of one or more immunosuppressive agents of the group consisting of adriamycin, cyclophosphamide, azathioprine, cyclosporine a, Busulfan, Fludarabine, 5-fluorouracil, methotrex Ate, mycophenolate mofetil, mycophenolate Sodium is a non steroidal anti-inflammatory Drug,Rapamycin and tacrolimus.The Method of claim 47: According to any one of claims 1 to 46, where the body is selected from the group consisting aloinjertado in kidney, Lung, Heart, pancreas, Liver vascular tissue, or one or more lobes of this Eye tissue, Skin, gastrointestinal, Gastr Or nervous tissue, Muscle, Bone or cartilage, Bone Marrow, connective tissue cells, red blood cells, IsletsCornea and lens of the eye. The Method of claim 61: According to any one of claims 1 to 60, where the Antibody anti CD200 is a Human Antibody, Chimeric Antibody, Humanized Antibody, Antibody of Rodent, an Antibody or an Antibody desinmunizado primatizado.The Method of claim 62: According to any one of claims 1 to 59 or 61, in which the Antibody anti CD200 is a fragment of CD200 Antibody fixation to a complete anti CD200.Claim 81: The Method according to claim 67, which Selects at least one of one or more immunosuppressive agents of the group consisting of adriamycin, cyclophosphamide, azathioprine, cyclosporine a, Busulfan, Fludarabine, 5-fluorouracil, methotrexate, mycophenolate mo Fetil, mycophenolate Sodium is a non steroidal anti-inflammatory Drug, Rapamycin and tacrolimus.
机译:本说明书还提供了生物标记,其中的一种或多种变化表明抗体抗CD200已成为哺乳动物所需的免疫调节作用。还提及的是包含至少一种抗体抗CD200的药物组合物,试剂盒和溶液,并且可用于本文所述的方法。权利要求1:延长肾脏同种异体移植物存活的方法。所述方法包括向有需要的哺乳动物施用所述CD200抗体作为单一试剂的量并且通常有效地延长同种异体移植物在哺乳动物宿主中的存活。权利要求32:根据权利要求21至25所述的方法,其选择阿霉素,环磷酰胺,硫唑嘌呤,环孢霉素a,白消安,氟达拉滨,5-氟尿嘧啶,甲氨蝶呤Ate,霉酚酸酯,霉酚酸酯钠,非甾体类抗炎药,雷帕霉素和权利要求47的方法:权利要求1至46中任一项的方法,其中所述身体选自肾脏,肺,心脏,胰腺,肝血管组织或该眼组织的一个或多个叶的阿隆杰多多,皮肤,胃肠道,胃或神经组织,肌肉,骨骼或软骨,骨髓,结缔组织细胞,红细胞,胰岛角膜和眼球。 63.根据权利要求1至60中任一项所述的方法,其中,所述抗体抗CD200是人抗体,嵌合抗体,人源化抗体,啮齿动物抗体,抗体或原发性抗体。权利要求62所述的方法: 60.根据权利要求1至59或61中任一项所述的方法,其中所述抗体抗CD200是将CD200抗体固定至完整抗CD200的片段。81.根据权利要求67所述的方法,其选择一种或多种中的至少一种免疫抑制剂包括阿霉素,环磷酰胺,硫唑嘌呤,环孢菌素a,白消安,氟达拉滨,5-氟尿嘧啶,甲氨蝶呤,霉酚酸酯,非甾体,霉酚酸酯钠是非甾体类抗炎药,雷帕霉素和他克莫司。

著录项

  • 公开/公告号AR085141A1

    专利类型

  • 公开/公告日2013-09-11

    原文格式PDF

  • 申请/专利权人 ALEXION PHARMACEUTICALS INC.;

    申请/专利号AR2012P100369

  • 发明设计人

    申请日2012-02-03

  • 分类号A61K39/395;A61P37/06;

  • 国家 AR

  • 入库时间 2022-08-21 16:42:31

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号